WallStreetZenWallStreetZen

NASDAQ: VRNA
Verona Pharma PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VRNA past revenue growth

How has VRNA's revenue growth performed historically?
Company
-100%
Industry
144.63%
Market
17.55%
VRNA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VRNA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

VRNA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$54.4M
Current Profit Margin
0%

VRNA Return on Equity

Current Company
-20.5%
Current Industry
-63.5%
Current Market
188%
VRNA's Return on Equity (-20.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VRNA announces earnings.

VRNA Return on Assets

Current Company
-17.7%
Current Industry
2.9%
VRNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VRNA Return on Capital Employed

Current Company
-17.31%
Current Industry
19.5%
VRNA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VRNA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VRNA$0.00-$51.16M-$54.37M-100.00%N/A
LGNDN/AN/AN/AN/AN/A
KNSA$301.77M-$16.36M$8.65M+106.55%-95.74%
SLNO$0.00-$36.71M-$38.99MN/AN/A
XNCR$168.34M-$108.78M-$126.09M+32.90%N/A
View Top Biotech Stocks

VRNA earnings dates

Next earnings date
May 9, 2024

Verona Pharma Earnings & Revenue FAQ

What were VRNA's earnings last quarter?

On Invalid Date, Verona Pharma (NASDAQ: VRNA) reported Q4 2023 earnings per share (EPS) of -$0.24, up 200% year over year. Total Verona Pharma earnings for the quarter were -$14.13 million. In the same quarter last year, Verona Pharma's earnings per share (EPS) was -$0.08.

If you're new to stock investing, here's how to buy Verona Pharma stock.

What was VRNA's earnings growth in the past year?

As of Q2 2024, Verona Pharma's earnings has grown year over year. Verona Pharma's earnings in the past year totalled -$54.37 million.

What is VRNA's earnings date?

Verona Pharma's earnings date is Invalid Date. Add VRNA to your watchlist to be reminded of VRNA's next earnings announcement.

What was VRNA's revenue last quarter?

On Invalid Date, Verona Pharma (NASDAQ: VRNA) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Verona Pharma's revenue was $458.00 thousand.

What was VRNA's revenue growth in the past year?

As of Q2 2024, Verona Pharma's revenue has grown -100% year over year. This is 244.63 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Verona Pharma's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.